Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | What role does amyloid-β and tau play in AD?

Claire Durrant • 9 Apr 2020
ARUK 2020
Alzheimer’s Disease Dementia

Claire Durrant, PhD, Centre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK, discusses the roles of two specific proteins in Alzheimer’s disease (AD) pathology, beta-amyloid and tau. Dr Durrant highlights how both proteins are important targets for future dementia treatments. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Claire Durrant

Exploring AD pathology using organotypic brain slice cultures
5:24
Exploring AD pathology using organotypic brain slice cultures
Claire Durrant • 9 Apr 2020
Organotypic brain slice cultures for the study of AD: impact and potential directions
1:45
Organotypic brain slice cultures for the study of AD: impact and potential directions
Claire Durrant • 9 Apr 2020
Immune-response in Alzheimer's disease
0:56
Immune-response in Alzheimer's disease
Claire Durrant • 9 Apr 2020
Organotypic brain slice cultures: a model to study AD
1:00
Organotypic brain slice cultures: a model to study AD
Claire Durrant • 9 Apr 2020

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals